Key Documents

View All Documentation

A0325000

Alanine

Name: Alanine
Brand: SIAL

European Pharmacopoeia (EP) Reference Standard

Synonym(s):

L-Alanine, (S)-2-Aminopropionic acid, L-α-Aminopropionic acid

Select a Size

Change View

About This Item

Empirical Formula (Hill Notation):

C₃H₇NO₂

CAS Number:

56-41-7

Molecular Weight:

89.09

UNSPSC Code:

41116107

NACRES:

NA.24

PubChem Substance ID:

329770597

MDL number:

MFCD00064410

Beilstein/REAXYS Number:

1720248

Technical Service

Need help? Our team of experienced scientists is here for you.

Let Us Assist

Properties

grade

pharmaceutical primary standard

API family

alanine

manufacturer/tradename

EDQM

application(s)

pharmaceutical (small molecule)

format

neat

storage temp.

2-8°C

InChI

1S/C3H7NO2/c1-2(4)3(5)6/h2H,4H2,1H3,(H,5,6)/t2-/m0/s1

InChI key

QNAYBMKLOCPYGJ-REOHCLBHSA-N

Description

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.
For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Alanine EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Packaging

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Other Notes

Sales restrictions may apply.

Storage Class

11 - Combustible Solids

wgk

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Worsening heart failure, a critical event during hospital admission for acute heart failure: results from the VERITAS study.

Gad Cotter et al.

European journal of heart failure, 16(12), 1362-1371 (2014-11-06)

Worsening heart failure (WHF) in the first 7 days after an admission for acute HF (AHF) has been proposed as a therapeutic target in several recent AHF studies and was a co-primary endpoint of the VERITAS studies. Patients were randomized

Prediagnostic circulating vitamin D levels and risk of hepatocellular carcinoma in European populations: a nested case-control study.

Veronika Fedirko et al.

Hepatology (Baltimore, Md.), 60(4), 1222-1230 (2014-03-20)

The association between vitamin D status and hepatocellular carcinoma (HCC) has not been well investigated, despite experimental evidence supporting an important role of vitamin D in liver pathophysiology. Our objective was to investigate the association between prediagnostic circulating 25-hydroxyvitamin D

Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: a randomised trial.

Chen-Hua Liu et al.

Gut, 64(2), 303-311 (2014-04-22)

Data comparing the efficacy and safety of combination therapy with peginterferon plus low-dose ribavirin and peginterferon monotherapy in treatment-naive haemodialysis patients with hepatitis C virus genotype 2 (HCV-2) infection are limited. In this randomised trial, 172 patients received 24 weeks of

View All Related Papers

Global Trade Item Number

SKU	GTIN
A0325000	04061833791257